United States · FDA National Drug Code directory
Paliperidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 27808-225_ffd2bfbd-11f5-436a-9ebf-bbd4ef92bacd
- Product NDC
- 27808-225
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- paliperidone
- Labeler
- Tris Pharma Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201029
- Source listing expiry
- 20261231
Source-listed ingredients
- PALIPERIDONE — 9 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27808-225-01) · 27808-225-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →